Universality and Structure of the N-end Rule by Gonda, David K. et al.
THE JOURNAL OF BIOLOGICAL  CHEMISTRY 
0 1989 by The American Society for Biochemistry and Molecular Biology, Inc. Vol. 264, No. 28, Issue of October 5, pp. 16700-16712,1989 Printed in U.S.A. 
Universality and Structure of the  N-end Rule* 
(Received for publication,  February 2, 1989) 
David K. GondaSB, Andreas BachmairSlI, Ingrid Wunning$II , John W. Tobias$, William S. Lane$$, 
and Alexander Varshavsky$** 
From  the  $Department of Biology, Massachusetts  Institute of Technology,  Cambridge,  Massachusetts 02139 and the  StHarvard 
Biological Laboratories, Harvard  Microchemistry Facility, Harvard  University, Cambridge, Massachusetts 02138 
Our previous work has shown that, in the yeast 
Saccharomyces cerevisiae, any of  the  eight stabilizing 
amino-terminal residues confers a long (>20 h)  half- 
life on a test protein &galactosidase @gal),  whereas 12 
destabilizing amino-terminal residues confer on @gal 
half-lives from less than 3 min to 30 min. We now show 
that an analogous single-residue code (the N-end rule) 
operates in an in vitro system  derived from mammalian 
reticulocytes. We also  show that the N-end rule  has a 
hierarchical structure. Specifically, amino-terminal 
Glu and Asp (and also Cys in reticulocytes)  are second- 
ary destabilizing residues in that they  are destabilizing 
through their ability  to be conjugated to primary de- 
stabilizing residues such as Arg. Amino-terminal Gln 
and  Asn are tertiary destabilizing residues in that they 
are destabilizing through their  ability  to  be converted, 
via selective deamidation, into secondary destabilizing 
residues Glu and Asp. Furthermore, in reticulocytes, 
distinct types of the N-end-recognizing activity are 
shown  to  be  specific for three  classes of primary desta- 
bilizing residues: basic (Arg, Lys,  His), bulky hydro- 
phobic (Phe, Leu, Trp, Tyr), and small uncharged (Ala, 
Ser,  Thr). Features of the  N-end rule in  reticulocytes 
suggest that the exact form of the N-end rule may 
depend on the cell’s physiological state, thereby pro- 
viding a mechanism for selective destruction of  preex- 
isting proteins upon cell  differentiation. 
The half-lives of intracellular proteins range from a few 
seconds to many days. Rates of selective protein degradation 
are a  function of the cell’s physiological state  and appear to 
be controlled differentially for individual proteins. In partic- 
ular, most of the damaged and otherwise abnormal  proteins 
are metabolically unstable (reviewed by Finley and Varshav- 
sky, 1985; Hershko and Ciechanover, 1986; Bond and Butler, 
1987;  Dice,  1987; Hershko, 1988; Arfin and Bradshaw, 1988). 
Many undamaged proteins are also short-lived i n  vivo (Gottes- 
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man et al., 1981; Spindler and Berk, 1984; Cheng and Echols, 
1987). Metabolic instability of these  proteins allows for effi- 
cient temporal control of their intracellular concentrations 
and  has been shown to be essential for the regulatory func- 
tions of several eukaryotic and bacterial  proteins (Nasmyth, 
1983; Ho et al., 1986; Banuett et al., 1986; Straus et al., 1987; 
Bahl et al., 1987; Shanklin et al., 1987). Many other proteins, 
while long-lived as components of larger macromolecular com- 
plexes such as ribosomes and oligomeric proteins, are meta- 
bolically unstable  in  a free, unassociated state (Maicas et al., 
1988; Tsay et al., 1988). 
Most of the selective degradation of intracellular  proteins 
under  normal metabolic conditions is adenosine triphosphate 
(ATP)-dependent and (in eukaryotes) nonlysosomal. Both 
biochemical and genetic evidence indicates that, in eukar- 
yotes, covalent conjugation of ubiquitin,  a 76-residue protein, 
to short-lived  intracellular  proteins is essential for their se- 
lective degradation (Hershko et al., 1980; Finley et  al., 1984; 
Ciechanover et al., 1984). This understanding, however, leaves 
unsolved the problem of targeting: how are  intracellular  pro- 
teins initially recognized as proteolytic substrates? Using a 
new approach, which makes it possible to expose i n  vivo 
different amino acid residues at  the amino termini of other- 
wise identical test proteins, we have found that, in the yeast 
S. cerevisiae, an  important component of a protein’s degra- 
dation signal is remarkably simple and consists of the pro- 
tein’s amino-terminal residue (Bachmair et al., 1986). The 
resulting code or rule that relates the protein’s metabolic 
stability and the nature of its amino-terminal residue has 
been called the N-end rule (Bachmair et al., 1986). 
In  the present work, we show that  an  N-end rule similar, 
but  not identical to  the yeast N-end rule can be defined in 
mammalian reticulocytes. Certain  features of the reticulocyte 
N-end rule suggest that  an N-end  rule-mediated degradative 
pathway may underlie selective destruction of preexisting, 
otherwise long-lived proteins upon cell differentiation. We 
also show that  the N-end rule is organized hierarchically, and 
analyze mechanistic aspects of its organization. 
EXPERIMENTAL  PROCEDURES 
Expression Vectors Encoding Ub-X-@gal Proteins-Four of the 
pKKUb-X-@gal vectors (those encoding Ub-Met-@gal, Ub-Gln-@gal, 
Ub-Arg-@gal, and Ub-Pro-@gal) were constructed as follows. Oligo- 
nucleotide-directed mutagenesis (Smith, 1985; Ausubel et al., 1987) 
was used to  insert  the sequence GTAC between the first and second 
codons of the ubiquitin  reading  frame in the yeast expression vector 
pUB23 (which encodes Ub-Met-@gal) and in its derivatives (Bachmair 
et al., 1986) encoding Ub-Arg-pgal, Ub-Gln-@gal, and Ub-Pro-@gal. 
The insertion created a KpnI site positioned such that when the 
vector is cut with KpnI and  the  ends blunted by mung  bean nuclease, 
the second codon of the ubiquitin  reading  frame starts precisely at 
one of the fragment’s ends. Thus, digestion of each of the above four 
vectors with KpnI and Tthl l l I ,  followed by treatment with mung 
bean nuclease, yielded four fragments which contained the corre- 
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sponding Ub-X-pgal-codling sequences but lacked the first (ATG) 
codon of the ubiquitin reading frame. These  fragments were subcloned 
into an Escherichia coli expression vector pKK233-2 (Amann and 
Brosius, 1985) which had been prepared by digesting with NcoI and 
filling in staggered ends using Klenow fragment of Pol1 (Ausubel et 
al., 1987). This step yielded the complete Ub-X-@gal sequence (in 
which the ATG codon was supplied by the pKK233-2 vector),  opti- 
mally positioned downstream of the  Ptrc promoter of the vector. To 
construct the remaining 16 pKKUb-X-pgal expression vectors, 
pKKUb-Arg-@gal was digested with Sal1 and BamHI. One of the two 
BamHI sites in pKKUb-Arg-@gal is located at  the junction between 
the ubiquitin- and @gal-coding sequences; the other BamHI site, 
present in the initial pKK233-2 vector (Amann and Brosius, 1985), 
was removed in a preliminary construction step. The small SalI/ 
BamHI fragment (containing the  Ptrc promoter, the complete ubiqui- 
tin-coding sequence, and  the Arg codon at  the Ub-@gal junction) was 
subcloned into a M13mp!f vector (Messing and Vieira, 1982;  Ausubel 
et al., 1987). A BstXIIBamHI fragment of this construct that con- 
tained  a portion of the ubiquitin-coding sequence and  the Arg  codon 
at  the Ub-@gal junction, was then exchanged for the 16 otherwise 
identical BstXIIBamHI  fragments (from the previously made, 
M13mp9-based constructs (Bachmair et al., 1986)) which differed 
exclusively in a codon a.t the Ub-pgal junction. The resulting 16 
M13mp9-based constructs were treated with Sal1 and BamHI, and 
the small SalIIBamHI fragments containing the ubiquitin-coding 
sequence and different single codons at  the Ub-pgal junction were 
cloned back into pKKUb-Arg-pgal, replacing the original SalI/ 
BamHI fragment, and yielding the remaining sixteen pKKUb-X-pgal 
expression vectors. In all cases, the identity of the amino acid encoded 
at the Ub-@gal junction of a final pKKUb-X-@gal construct was 
verified by subcloning into  MI3  and nucleotide sequencing by the 
chain termination method (Ausubel et al., 1987). 
Production of X-pgal by Cleavage with Factor Xa Protease-The 
small SalIIBamHI fragment of pKKUb-Phe-pgal (see above) was 
subcloned into M13mp19 (Messing and Vieira, 1982;  Ausubel et al., 
1987) where the last four codons of the ubiquitin reading frame were 
changed, using oligonucleotide-directed mutagenesis, into those en- 
coding the recognition site (-Ile-Glu-Gly-Arg-) for Factor Xa protease 
(Nagai and Thogersen, 1987). The mutagenesis protocol was that 
specified by the Bio-Rad Mutagene Kit (Bio-Rad). The desired mu- 
tants were identified by sequencing of DNA (Ausubel et al., 1987) 
from individual phage isolates. The construct obtained was subjected 
to a second round of oligonucleotide-directed mutagenesis to change 
Phe, which abuts the carboxyl-terminal end of the Factor Xa  cleavage 
site, into Gln. The resulting M13mpl9-based construct and the 
pKKUb-Phe-pgal vector (see above) were both cut with Sal1 and 
BamHI, and  the small SalIIBamHI fragment of the M13mpl9-based 
construct was ligated to  the large SalIIBarnHI fragment of pKKUb- 
Phe-pgal, yielding the expression vector pKKUb-(Xa)-Gln-pgal. The 
corresponding protein, Ub- (Xa)-Gln-pgal (in which the last 4 residues 
of ubiquitin were changed as described above) was overexpressed in 
E.  coli (strain MV1190) and purified by affinity chromatography (see 
below). The purified Ub-(Xa)-Gln-pgal (0.1-0.3 mg/ml) was incu- 
bated for 24 h at room temperature in 12% glycerol, 0.35 M NaCl, 
0.25 mM MgC12, 0.11 M Tris-HC1, pH 8.3, containing 1 mg/ml bovine 
serum albumin and 5 units/ml of Factor Xa from human plasma 
(Boehringer Mannheim). Cleavage of Ub-(Xa)-Gln-pgal with Factor 
Xa was verified by SDS-PAGE' and by amino acid sequencing (see 
below). Otherwise identical digestions of Ub-Gln-@gal that lacked the 
Factor Xa cleavage site did not yield proteolytic fragments. 
Purification of  Ub-X-@gcd Proteins Expressed in E. coli-An over- 
night culture (1 ml) of E. coli JMlOl cells bearing one of the 20 
pKKUb-X-@gal expression vectors (see above) was diluted into 50 ml 
of Luria broth supplemented with ampicillin at 40 pg/ml, and  the 
cells were  grown with shaking for approximately 2 h at 37 "C. The 
cells were harvested by centrifugation at 4,000 X g for 10 min, washed 
twice with M9 buffer, and resuspended in 25 ml of M9 minimal 
medium supplemented with glucose (0.22%, w/v), thiamine (18 pg/ 
ml), ampicillin (40 pg/ml), 0.5 mM isopropylthiogalactoside, and 0.15 
ml of 10.5% (w/v) Methionine Assay Medium (Difco). After incuba- 
tion with shaking for 1 h at 37 "C, 0.5-1.0 mCi of Tran~-~~S- labe l  
(ICN; -85% [35S]methionine, -15% [35S]cysteine) was added and 
shaking was continued for 5 min. Unlabeled L-methionine was then 
added to 1 mM and shaking was continued for another 10 min. Cells 
'The abbreviations used are: SDS-PAGE, sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis; DTT, dithiothreitol;  APTG,  ami- 
nophenylthiopyranoga1acto:side. 
were harvested, washed twice with M9 buffer, and resuspended in 0.5 
ml  of 25% (w/v) sucrose, 50 mM Tris-HC1, pH 8.0. Thereafter, 0.1  ml 
of lysozyme (10 mg/ml; Sigma) in 0.25 M Tris-HC1, pH 8.0, was 
added, and  the mixture was incubated at 0 "C for 5 min, followed by 
the addition of 0.1 ml of 0.5 M Na-EDTA, pH 8.0, and further 
incubation at 0 "C for 5 min. The cell suspension was then added to 
a lysis solution (0.8 ml HzO, 50  pl of 1 M Tris-HC1, pH 8.0, 125 p1 of 
0.5 M Na-EDTA, pH  8.0,lO pl of 10%  (v/v) Triton  X-loo),  and gently 
mixed. The lysate was centrifuged at  40,000 X g for 1 h, and Ub-X- 
Pgal  was purified from the  supernatant by affinity chromatography 
on aminophenylthiopyranogalactoside-Sepharose (APTG-Sepha- 
rose) as described by Ullman (1984). Ubiquitin-X-pgal was eluted 
from APTG-agarose with 10 mM 2-mercaptoethanol, 0.1 M Na-borate, 
pH 10.0, dialyzed overnight at 4 "C against 50% (v/v) glycerol, 0.1 
mM EDTA, 1 mM dithiothreitol (DTT), 1 mM MgClz, 40 mM Tris- 
HCI, pH 7.5, and stored at -20  "C in the same buffer. Control 
experiments showed that  the transient exposure of LJb-X-pgal to  the 
high pH elution buffer does not result in a detectable change of pgal 
enzymatic activity. Typical yields of [35SJUb-X-pgal purified by the 
above procedure were  0.5-1  mg, with enzymatic activity of  4-6 X 10' 
units/mg and specific radioactivity of 1-2 X lo5 cpmlpg. Unlabeled 
Ub-X-@gal was prepared essentially as described above except that 
after 2 h of growth in Luria broth with ampicillin, isopropylthioga- 
lactoside was added to 0.5  mM, and  the cells were  grown for one more 
hour before harvesting and lysis. 
In Vitro Assays with Reticulocyte Extract-Washed reticulocytes 
from phenylhydrazine-treated rabbits were purchased from Green 
Hectares (Oregon, WI) and shipped overnight a t  0 "C. The reticulo- 
cytes were washed three times with 3-4 volumes of standard phos- 
phate-buffered saline (centrifugations at  1,000 X g for 10 min at 4 "C). 
To deplete intracellular ATP (Hershko  et al., 1980), the cells were 
incubated for 90 min at  37 "C in Krebs-Ringer phosphate buffer 
containing 0.2 mM 2,4-dinitrophenol and 20 mM 2-deoxyglucose, and 
then washed three times in phosphate-buffered saline. Pelleted retic- 
ulocytes were then lysed at  0 "C by resuspending the pellet in 1.5 
volumes of 1 mM DTT. After -10 min at 0 "C, the sample was 
centrifuged at 80,000 X g for 90 min at 4 "C. The  supernatant was 
removed,  divided into aliquots, and stored under liquid nitrogen. Only 
once-frozen aliquots were used in all experiments. Unless stated 
otherwise, the ATP-depleted reticulocyte extract was used directly 
after thawing, without further processing. In some experiments, the 
thawed extract was first dialyzed overnight a t  4 "C against 1 mM 
DTT, 10 mM Tris-HC1, pH 7.5, in dialysis tubing with a M, cutoff of 
-3 kDa. Fraction I1 was prepared by DEAE chromatography of ATP- 
depleted reticulocyte extract as previously described (Hershko  et al., 
1980) and stored under liquid nitrogen. Reaction mixtures for assay- 
ing the degradation of test proteins  in  either the total reticulocyte 
extract or Fraction I1 contained (final concentrations) 5% (v/v) 
glycerol, 1 mM DTT, 5 mM MgCl2, 50 mM Tris-HC1, pH 7.5, 70% (v/ 
v) reticulocyte extract  (or  Fraction I1 at 6 mg/ml of the total  protein), 
[35S]Ub-X-pgal fusion protein at 20 pg/ml, and, when present, 0.5 
D M  ATP and  an ATP-regenerating system (10 mM creatine phos- 
phate, 0.1 mg/ml creatine phosphokinase). Reaction mixtures were 
prepared as follows: a mixture complete except for ATP and ATP- 
regenerating system was incubated for 10 min at  37 "C to allow for 
the deubiquitination of a Ub-X-@gal fusion protein (see Fig.  2, lanes 
d-0); ATP  and ATP-regenerating system were then added to  start 
the ATP-dependent reactions in the extract  (time zero in Figs. 3 and 
41, and  the 37 "C incubation continued. Reaction mixtures containing 
Fraction I1 were also supplemented with purified ubiquitin at 0.1  mg/ 
ml. Control reactions with the ATP-depleted extract were performed 
identically except that ATP and ATP-regenerating system were omit- 
ted. The ATP-dependent degradation of '251-labeled bovine serum 
albumin, hen lysozyme, and cytochrome c from S. cerevisiae (pur- 
chased from Sigma, and labeled using the chloramine-T method 
(Hershko  et al., 1980)) was assayed as described above except that 
the 10-min preincubation of the  test protein at 37 "C in the ATP- 
depleted reticulocyte extract was omitted. To follow the degradation 
of test proteins, aliquots were taken from the reaction mixture at  the 
indicated times, and either assayed for the amount of 5% trichloroa- 
cetic acid-soluble radioactivity present, or analyzed by SDS-PAGE 
(Laemmli, 1970; Ausubel et al., 1987) (8% polyacrylamide, 0.05% 
bisacrylamide, 15 X 15 X 0.15 cm gels), with subsequent fluorography. 
Amino Acid Sequencing-For the amino acid sequencing by auto- 
mated Edman degradation, X-pgal test proteins were reisolated by 
immunoprecipitation with a monoclonal antibody to pgal (Bachmair 
et al., 1986) from either reticulocyte extract, reticulocyte Fraction I1 
(see above), or extracts made from pgal-containing yeast cells (Bach- 
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mair et al., 1986 Bachmair and Varshavsky, 1989). The immunopre- 
cipitated X-@gal proteins were subjected to SDS-PAGE and then 
electroblotted onto polyvinylidene difluoride  membrane  (Matsudaira, 
1987). Amino acid sequencing of  10-30 pmol of electroblotted  protein 
was carried  out for a  minimum of 5 cycles using an Applied Biosys- 
tems 470A Protein Sequencer equipped with an online 120A PTH 
Analyzer. 
RESULTS 
Expression and Purification  of Ub-@gal Fusion  Proteins- 
To produce otherwise identical @-galactosidase (pgal) test 
proteins bearing different amino-terminal residues, Bachmair 
et al. (1986) used a  construct that expresses a ubiquitin-@gal 
fusion protein in yeast. The nascent Ub-pgal is rapidly and 
precisely deubiquitinated i n  vivo by an endogenous processing 
protease to yield a @gal test protein  bearing the desired amino- 
terminal residue (Fig. 1, A and B, and Table I; see also 
Bachmair et al., 1986; Bachmair and Varshavsky, 1989). 
In the present work, the ubiquitin fusion approach (Fig. 
IC) was used to analyze the N-end rule in an extensively 
characterized in  vitro ATP-dependent proteolysis system 
(Etlinger and Goldberg, 1977; Hershko et al., 1980; Hershko, 
1988) derived from rabbit reticulocytes. We have constructed 
a set of E.  coli expression vectors encoding Ub-X-pgal fusion 
proteins which differ exclusively at residue X at  the Ub-Ogal 
junction (see “Experimental  Procedures”). Metabolically la- 
beled [35S]Ub-X-pgal proteins were purified from E. coli using 
affinity chromatography (Fig. 2, lanes a-c). None of the Ub- 
X-@gal proteins were significantly deubiquitinated or  other- 
wise degraded in E. coli, apparently because bacteria lack the 
eukaryotic ubiquitin system (Bachmair et al., 1986; Finley et 
al., 1988). 
Deubiquitination of Ub-X-pgal Fusion Proteins in ATP- 
depleted  Reticulocyte Extract-Each of the 20 35S-labeled Ub- 
X-@gal proteins was added to  an  extract prepared from ATP- 
depleted rabbit reticulocytes (see “Experimental  Proce- 
dures”), and  the fates of the added proteins were  followed  by 
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FIG. 1. The use of ubiquitin-Bgal fusions to generate pgal 
test proteins bearing different amino-terminal residues. A, the 
residue X at  the Ub-pgal  junction was manipulated  (by  site-directed 
mutagenesis of the gene encoding Ub-Met-pgal) to generate 20 ub- 
X-pgal proteins that differ exclusively at  residue X (Bachmair et al., 
1986). An arrowhead indicates the site of the deubiquitinating cleav- 
age that occurs immediately after the  last (Gly-76) residue of ubiquitin 
and yields @gal bearing  a new amino-terminal residue, X. E, the use 
of Ub-X-@gal proteins as in uiuo proteolytic substrates. C, the use of 
Ub-X-&a1 proteins  as in uitro proteolytic substrates. 
SDS-PAGE (Fig. 2, lanes d-s). As has been previously ob- 
served with the same  ubiquitin  fusions in yeast cells (Bach- 
mair et al., 1986), an apparently ubiquitin-specific protease  in 
reticulocyte extract deubiquitinated the added Ub-X-pgal fu- 
sion proteins to yield the corresponding X-pgal test proteins. 
The deubiquitination of 19 of the 20 Ub-X-pgal proteins  in 
the ATP-depleted extract was more than 90% complete in 5 
min at 37 “C (Fig. 2, lanes d-0, Table I, and  data not shown). 
The single exception, both in yeast (Bachmair et al., 1986) 
and in reticulocytes, is Ub-Pro-pgal, which was deubiquitin- 
ated approximately 20 times more slowly than were the  other 
Ub-X-@gal proteins (Fig. 2, lanes p-s, and  data  not shown). 
Amino acid sequencing (by Edman degradation) of deubi- 
quitinated @gal proteins reisolated from either reticulocyte 
extract or yeast cells showed that,  in every case, the proteo- 
lytic cleavage occurred precisely at the Ub-pgal junction 
(Table I), as previously inferred by Bachmair et al. (1986) 
from less extensive evidence. Although sequencing revealed 
that  the amino termini of some X-pgal proteins  underwent 
specific modifications (see Table I and below), in no case did 
these modifications involve proteolytic cleavages beyond the 
amino-terminal residue X (Table I). 
All  of the deubiquitinated X-pgal proteins were metaboli- 
cally stable in  the ATP-depleted reticulocyte extract  as judged 
by SDS-PAGE  analysis (Fig. 2, lanes d-s, Fig. 3A, lanes b-f, 
and  data  not shown) and from the negligible production of 
acid-soluble radioactivity in the extract ((0.2% in 2 h at  
37 “C; Fig. 4B). Thus, preincubation of the Ub-X-Ogal fusion 
proteins in the ATP-depleted reticulocyte extract made it 
possible to generate 20 X-@gal test proteins which differed 
exclusively at  the amino-terminal residue X. 
Half-life of  an X-pgal Protein in ATP-supplemented  Retic- 
ulocyte Extract Is a Function  of  the X-pgal’s Amino-terminal 
Residue-While all of the 20 X-@gal  proteins were metaboli- 
cally stable in the ATP-depleted reticulocyte extract (see 
above), most of them became short-lived upon addition of 
ATP  to  the  extract (Table I and Fig. 4, B-F). To simplify the 
discussion, we refer to  an amino-terminal residue as stabiliz- 
ing if the corresponding X-@gal is relatively long-lived in the 
ATP-supplemented extract (<lo% degradation in 2 h at 
37 “C), and as destabilizing if the degradation of the corre- 
sponding X-@gal in the  extract exceeds 15%  under the same 
conditions (Table I and Fig. 4). While heuristically useful, 
this classification is oversimplifying in that  it ignores rela- 
tively small but reproducible and potentially significant dif- 
ferences among the metabolic stabilities of the relatively long- 
lived X-pgal proteins. For example, in this classification, Ile, 
a destabilizing residue in yeast, is a stabilizing residue in 
reticulocytes (Table I), although Ile-@gal is degraded signifi- 
cantly (and reproducibly) faster than  the  other long-lived X- 
@gal proteins  in the ATP-supplemented reticulocyte extract 
(Table I). 
The time courses of degradation for several X-@gal  proteins 
contained reproducible initial lags (see, for example, the time 
course for Arg-pgal in Fig. 4B). However, semilogarithmic 
plots of the time courses in Fig. 4 showed that,  after  the initial 
lags, the degradation of X-pgal in the ATP-supplemented 
reticulocyte extract obeyed first-order kinetics for at  least the 
first 2 h, making it possible to compare the degradation of 
different X-@gal proteins by comparing their half-lives in the 
extract (Table 1). The range of @gal half-lives in the reticu- 
locyte extract encompasses more than two orders of magni- 
tude (Table I). Half-lives of the metabolically unstable X- 
pgal proteins  in reticulocyte extract (Table I) were comparable 
to the half-lives of other proteolytic substrates (iodinated 
serum albumin, lysozyme, and cytochrome c )  in the same 
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TABLE I 
The  N-end rule in  yeast  and  in  mammalian reticulocytes 
The in vivo half-lives of X-@gal test  proteins in the yeast S. cerevisiae were determined as previously described 
(Bachmair et al., 1986). The yeast N-end rule as reported by Bachmair et al. (1986) is  updated here by inclusion of 
the four  remaining amino acids, Cys, His, Trp,  and Asn (see also  Bachmair and Varshavsky, 1989). The half-lives 
of purified, 35S-labeled X-@gal test proteins in the  ATP-supplemented reticulocyte extract were estimated from 
semilogarithmic  plots of the degradation  time courses in Fig. 4 (see  main text).  The half-lives thus determined 
were reproducible among  different preparations of the  extract  and of X-@gal test  proteins  (data  not shown). Amino 
acid sequencing of reisolated X-@gal proteins is described under  “Experimental Procedures.” When  a  mixture of 
two sequences was obtained,  both of the deduced sequences (separated by +) were included into  the table. 
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“Determined by radiochemical sequencing (Bachmair et al., 1986). 
This X-/?gal protein was incubated in ATP-depleted reticulocyte extract for 20 min at  37°C before reisolation 
and sequencing. 
‘This X-,Sgal test protein was incubated in ATP-supplemented reticulocyte extract for 1 h at  37°C before 
reisolation and sequencing. 
In both  yeast cells and reticulocyte extract, Ub-Pro-@gal  is  deubiquitinated  approximately 20 times more slowly 
than  are  the rest of the Ub-X-@gal fusion proteins (see  main text). Pro-@gal, the product of  slow deuibiquitination 
of Ub-Pro-@gal,  is  a long-lived protein  in  both yeast cells and reticulocyte extract. 
‘The S. cerevisiae strain used for expression of this X-pgal protein was BWG-Sa-1 ( M A T a ,  his4, ade6, u r d ) .  
’This @gal. protein was incubated for 2 h at  37°C in ATP-supplemented reticulocyte Fraction I1 before reisolation 
and sequencing. 
No signal was seen  upon sequencing of Ser-@gal  reisolated from yeast,  strongly suggesting that  the protein’s 
amino terminus was blocked. Note that Ser-@gal was not blocked when reisolated from ATP-supplemented 
reticulocyte extract. 
Cys-@gal was incubated in ATP-depleted reticulocyte extract for 30 min at  37°C before reisolation and 
sequencing. The  amino-terminal Cys, unmodified by alkylation before sequencing, could not be identified by the 
chromatographic  procedures used however, the second and subsequent sequencing steps unambiguously identified 
the  protein  as @gal. 
’ The S. cerevisiae strain used for expression of this X-@gal protein was a mutant (obtained in  the background 
of the BWG-Sa-1 strain) in which all of the otherwise short-lived (deubiquitinated) X-@gal test proteins are 
metabolically stable, whereas Ub-Pro-@gal is still short-lived (I. Wunning, A. Bachmair, and A. Varshavsky, 
unpublished data).  This  mutant (whose use allowed the isolation of the otherwise short-lived X-@gal proteins in 
quantities sufficient for sequencing) retains both the  intact “downstream”  degradation  pathway and  the  Ub-X- 
@gal deubiquitinating  activity but is  impaired in  the  amino-terminal recognition of at  least the X-@gal proteins. 
’ The  amino-terminal residue of this sequence could not be identified unambiguously with the  amount of @gal 
used (-15 pmol),  but, from the  data obtained, was most likely Arg. The  data clearly identified Glu as  the second 
residue. 
’ The frame-shifted sequence (?)-Glu-@gal was the more abundant (-90%) of the two sequences present. With 
the amount of @gal used (-15 pmol), the amino-terminal residue of this sequence could not be identified 
unambiguously but, from the  data obtained, was most likely Arg. 
extract (Fig. 4, A and €3, and  data  not shown).  These latter As described above, Ub-Pro-@gal is the only Ub-X-pgal 
test proteins have been used in  earlier  studies of ubiquitin- fusion protein whose deubiquitination is slow both in yeast 
dependent protein degradation in reticulocyte extract (re- and in reticulocyte extract. The product of deubiquitination, 
viewed by Hershko, 1988). Recently, at  least some of these Pro-pgal (whose expected amino-terminal sequence has been 
proteins have been shown to be targeted for degradation via directly confirmed; Table I), is long-lived in  both  yeast cells 
their destabilizing amino-terminal residues (Reiss et al., 1988). and reticulocyte extract (Table I). The metabolic stability of 
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FIG. 2. Purification of Ub-X-@gal  fusion  proteins and their 
deubiquitination in reticulocyte extract. %-Labeled proteins in 
lanes a-s were fractionated by SDS-PAGE and detected by fluorog- 
raphy. Lanes a-c, E. coli carrying an expression vector which encodes 
Ub-Gln-@gal were incubated with [“S]methionine, lysed, and  the “S- 
labeled Ub-Gln-@gal was purified from the extract in one step by 
affinity chromatography on APTG-Sepharose (see “Experimental 
Procedures”). Lane a, total E. coli extract. Lane b, flow-through 
fraction from the APTG-Sepharose column. Lane c, same as lane b 
but retained fraction. The same purification procedure was used with 
the other 19 Ub-X-@gal fusion proteins. Lanes d-s, equal amounts (1 
pg) of the purified, 3sSS-labeled Ub-X-@gal proteins were added sepa- 
rately to 50-pl samples containing 5% (v/v) glycerol, 5 mM MgC12, l 
mM DTT, 50 mM Tris-HCI, pH 7.5, and 70% (v/v) ATP-depleted 
reticulocyte extract. Aliquots were taken for analysis by SDS-PAGE 
after  0,5,15,  and 45 min of incubation at 37 “C. All  20  of the Ub-X- 
@gal proteins were analyzed this way. The fusion proteins  in the four 
examples shown here are Ub-Met-@gal (lanes d-g), Ub-Gln-@gal 
(lanes h-k), Ub-Arg-Bgal (lanes L o ) ,  and Ub-Pro-Bgal (lanes ps). 
Filled and open arrowheads indicate the bands of a -120-kDa Ub-X- 
@gal and a -112-kDa X-@gal, respectively. See “Experimental  Pro- 
cedures” for details. 
Pro-@gal is unrelated to  the slow deubiquitination of its pre- 
cursor, Ub-Pro-@gal:  when Pro-@gal was purified from ATP- 
depleted reticulocyte extract by affinity chromatography on 
APTG-agarose (see “Experimental Procedures”), and then 
added  back to ATP-supplemented reticulocyte extract, it re- 
mained as long-lived as  the Pro-@gal derived  from Ub-Pro- 
@gal directly in the  extract  (data not shown). 
While  in yeast the unprocessed (non-deubiquitinated) Ub- 
Pro-@gal is a short-lived protein, with a half-life of -7 min 
(Table I), it is, aside from its slow deubiquitination, a meta- 
bolically stable protein in the ATP-supplemented reticulocyte 
extract  (data not shown).  We  do not understand the reason 
for this difference  between the  fates of Ub-Pro-@gal in yeast 
cells and in reticulocyte extract. 
Degradation of X-@gal Proteins in Reticulocyte Fraction ZZ 
Zs Ubiquitin-dependent-To  remove free ubiquitin from the 
reticulocyte extract, it was fractionated by DEAE-chromatog- 
raphy to yield a fraction, called Fraction I1 (Hershko, 1988), 
which lacks most of the extract’s free ubiquitin but  retains 
the deubiquitinating activity and the ability to carry out 
ubiquitin-dependent protein degradation if supplemented 
with purified ubiquitin and  ATP (see “Experimental Proce- 
dures”). The degradation of X-@gal proteins (where X is Met, 
Val, Ser, Gln, Glu, Asp, Asn,  Cys, Ile, Phe, or Arg), and also 
of in vitro iodinated serum albumin and lysozyme, was ex- 
amined in Fraction I1 with and without added ATP and free 
ubiquitin. In agreement with earlier evidence (reviewed by 
Hershko and Ciechanover, 1986), the absolute rates of protein 
degradation in the ATP- and ubiquitin-supplemented Frac- 
tion I1  were significantly lower than those in the unfraction- 
ated, ATP-supplemented reticulocyte extract. Nevertheless, 
the degradation of X-@gal in Fraction I1  was still  a function 
of the protein’s amino-terminal residue and was completely 
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FIG. 3. Electrophoretic analysis of X-@gal degradation in 
reticulocyte extract. The 3sS-labeled @gal test proteins  in panels 
A-C were fractionated by SDS-PAGE and detected by fluorography. 
The filled arrowhead in A indicates the band of the initial, -120-kDa 
Ub-Glu-@gal fusion protein in lane a. The open arrowheads in panels 
A-C indicate the bands of (deubiquitinated) -112-kDa X-Bgal test 
proteins. The half-open square brackets in panels A-C indicate the 
bands of multiply ubiquitinated @gal. The arrow by lane n indicates 
the -90-kDa  cleavage product of X-@gal that accumulates during X- 
@gal degradation in yeast cells (Bachmair et al., 1986) but not in 
reticulocyte extract (see main text). Panel A, the Glu-@gal test protein 
(produced via deubiquitination of Ub-Glu-Bgal) was incubated in the 
reticulocyte extract in the absence (lanes b-f) or in the presence 
(lanes h-l) of ATP, and aliquots were taken for SDS-PAGE analysis 
after 0, 30, 60, 90, and 120 min a t  37 “C. Lane a contains the initial 
Ub-Glu-Bgal fusion protein. Lane g contains “C-labeled molecular 
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dependent on  the addition of ATP  and ubiquitin (data  not 
shown). Except where noted, the in vitro system used in  our 
further experiments was the unfractionated reticulocyte ex- 
tract because it is both more active in selective protein deg- 
radation and less perturbed (processed) than Fraction 11. 
Short-lived X-@gal ,Proteins Are  Multiply Ubiquitinated- 
Metabolically stable X-@gal proteins did not undergo either 
limited proteolysis or extensive ubiquitination during their 
incubation in the ATP-supplemented reticulocyte extract, as 
indicated by SDS-PAGE analysis, measurements of acid- 
soluble radioactivity, and direct sequencing of X-@gal proteins 
reisolated from the  extract (Figs. 3, B and C, and 4, and Table 
I).  In  contrast,  the d gradation of short-lived X-@gal proteins 
in  either the ATP-supplemented reticulocyte extract or the 
ATP- and ubiquitin-supplemented Fraction I1 was accom- 
panied by the formation of a set of higher molecular weight, 
X-@gal-containing species which was electrophoretically in- 
distinguishable from the previously observed set of ubiquitin- 
@gal conjugates formed during the in vivo degradation of 
short-lived X-@gal proteins  in yeast (Fig. 3A, lunes m and n; 
and B and C; see also 13achmair et a!., 1986). Direct mapping 
of ubiquitin moieties within multiply ubiquitinated X-@gal 
proteins has confirmed a close similarity, if not the identity 
of multiubiquitin arrangements in X-@gal isolated from yeast 
cells and from reticulocyte extract (Chau et al., 1989; see also 
“Discussion”). 
No discrete @gal  cleavage products were detectable by SDS- 
PAGE during the degradation of X-@gal proteins  in reticulo- 
cyte extract (Fig. 3 an.d data  not shown). In particular, no 
-9O-kDa, metabolically stable @gal  cleavage product that ac- 
cumulates  during the degradation of short-lived  X-@gal pro- 
teins in  yeast  (Bachmair et al., 1986) was observed during X- 
@gal degradation in reticulocyte extract (Fig. 3A, lunes h-n, 
and B) .  The degradation of an X-pgal is apparently highly 
processive, with intermediates (other  than multiply ubiquitin- 
ated @gal) that  are not detectable by SDS-PAGE analysis. 
With  three exceptions, the  steady-state levels of ubiquitin- 
@gal conjugates in reticulocyte extract closely correlated with 
the half-lives of corresponding X-@gal proteins (Fig. 3C). The 
exceptions, Ala-, Ser-, and Thr-@gal, attained significantly 
lower steady-state levels of ubiquitin-@gal conjugates than 
could be expected from comparisons with other X-@gal pro- 
teins of approximately equal metabolic stability (Fig. 3C). 
The  three relatively long-lived X-@gal proteins (Met-, Gly-, 
and Ile-@gal), but  not  the longest-lived Val-@gal, gave rise to 
low levels of steady-state ubiquitination (Fig. 3, B and C), 
~ 
mass markers (Amersham Corp.; 200, 100, 92.5, 69 and 46 kDa, 
respectively). Lanes m and. n, comparison of the multiply ubiquitin- 
ated @gal species formed dluring in vitro degradation of Gln-@gal in 
the reticulocyte extract (lane m )  with the analogous ubiquitin-pgal 
conjugates formed during in vivo degradation of Gln-@gal in the yeast 
S. cereuisiae (lane n). In the  latter case, the [35S]methionine-labeled 
pgal and  its ubiquitinated derivatives were isolated from yeast extract 
by immunoprecipitation wlth a monoclonal antibody to @gal (Bach- 
mair et al., 1986). B, Val-pgal (lanes a-d), Lys-pgal (lanes e-h),  and 
Phe-@gal (lanes i-1) were incubated in ATP-supplemented reticulo- 
cyte extract, and aliquots were taken for SDS-PAGE analysis after 
0, 30,60, and 120 min at 3;’ “C. C, equal amounts (1 pg) of 19 X-pgal 
proteins were incubated separately in  ATP-supplemented reticulocyte 
extract for 30 min at 37 “I:, followed by SDS-PAGE analysis. See 
“Experimental Procedures” for details. A letter below each lane refers, 
in a single-letter abbreviation, to  the amino-terminal residue X in 
the corresponding X-@gal. A number above each lane refers, in hours, 
to the approximate half-l~fe of the corresponding X-@gal in the 
reticulocyte extract (see Table  I). The order of lanes was chosen to 
approximate the order of metabolic stabilities of X-pgal test proteins 
in the reticulocyte extract (Fig. 4 and Table  I). Single-letter amino 
acid abbreviations: A, Ala; C ,  Cys; D, Asp; E, Glu; F ,  Phe; G ,  Gly; H, 
His; I, Ile; K ,  Lys; L, Leu; d l ,  Met; N ,  Asn; P, Pro; Q, Gln; R, Arg; S, 
Ser; T, Thr; V, Val; W, Trp; Y,  Tyr. 
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FIG. 4. ATP-dependent  degradation of test proteins in re- 
ticulocyte extract. Degradation of radioactively labeled test pro- 
teins was assayed by measuring acid-soluble radioactivity in either 
ATP-supplemented (closed symbols) or ATP-depleted (open symbols) 
reticulocyte extract. Panel A, test proteins were either bovine serum 
albumin (circles), cytochrome c from S. cereuisiae (squares), or hen 
lysozyme (triangles), all of which  were labeled with ‘‘‘I in vitro using 
the chloramine-T method (see “Experimental  Procedures”). Panels 
B-F, test proteins were the 20 X-pgal proteins produced by deubiqui- 
tination of the corresponding Ub-X-pgal fusion proteins that had 
been metabolically labeled with 35S. The letters marking each of the 
time courses refer, in single-letter abbreviations (see the legend to 
Fig. 3), to  the amino-terminal residue X in X-@gal. For all of the [36S] 
methionine-labeled X-@gal proteins, the amounts of acid-soluble ra- 
dioactivity released during a 2-h incubation at  37 “C in the ATP- 
depleted reticulocyte extract were  below 0.2% of the  input radioactiv- 
ity (panel B and  data  not shown). See “Experimental Procedures” 
for details. 
consistent with the fact that  the half-lives of these  proteins 
in reticulocyte extract were significantly shorter  than  that of 
Val-@gal (Table I). 
Primary and Secondary Destabilizing Residues-Earlier 
studies of ubiquitin-dependent  protein degradation in  reticu- 
locyte extract have shown that  the degradation of some pro- 
teolytic substrates in this system requires the presence of 
tRNA (Ferber and Ciechanover, 1986). The N-end rule (Bach- 
mair et al., 1986) provides a mechanistically straightforward 
explanation for the above observations. In  both bacteria and 
eukaryotes there exist  aminoacyl-tRNA-protein  transferases, 
which catalyze posttranslational conjugation of specific amino 
acids to  the mature  amino termini of acceptor proteins (Kaji 
et al., 1965; Soffer, 1980; Deutch, 1984). This  posttranslational 
conjugation of amino acids to proteins is greatly enhanced  in 
a  stressed or regenerating  tissue, for instance, in physically 
injured  axons of neurons (Ingoglia et al., 1983; Shyne-Athwal 
et al., 1986). We have previously suggested that certain  amino- 
terminal residues in  proteins may not be directly destabilizing 
as such but become so only through their ability to be conju- 
gated to  other, primary destabilizing residues (Bachmair et 
al., 1986). Later work (Ferber and Ciechanover, 1987) sup- 
ported this model by showing that several proteolytic sub- 
strates, whose only obvious common feature is the presence 
of an acidic amino-terminal residue (Glu or Asp), apparently 
required amino-terminal conjugation of Arg for their degra- 
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FIG. 5. Primary  and secondary  destabilizing amino acids. Panel A, metabolically unstable X-@gal proteins 
whose initial  amino-terminal residues are indicated below the bars, were incubated in ATP-supplemented reticu- 
locyte extract which had been pretreated for 45 min at  37 "C with 3 units/ml of RNase A-agarose (Sigma) and 
centrifuged to remove the immobilized RNase A before the addition of Ub-X-@gal. Closed bars indicate the extent 
of X-@gal degradation produced by the RNase A-pretreated extract. Identical results were obtained by preincubating 
the extract with 20 pg/ml of soluble RNase A (panel A and  data not shown). Open bars correspond to otherwise 
identical reactions in which the extract that had been pretreated with RNase A-agarose was supplemented with 50 
pg/ml of the purified total  tRNA from bovine liver and with 1500 units/ml of a RNase inhibitor RNasin (Promega 
Biotech; control experiments showed that RNasin alone had no effect on the same reactions). Degradation of these 
[RsS]methionine-labeled X-@gal proteins was assayed by measuring the amount of acid-soluble "S radioactivity 
after 2 h at 37 "C and is presented relative to  the degradation of X-@gal in corresponding control reactions, carried 
out in parallel and otherwise identically but without RNase A pretreatment or addition of tRNA. Pretreatment of 
reticulocyte extract with RNase A did not  inhibit deubiquitination of any of the Ub-X-@gal test proteins (data  not 
shown). Panel B, inhibition of X-@gal degradation in reticulocyte extract  as a function of the  extent of RNase A 
treatment. Reactions were carried out with 35S-labeled X-@gal proteins as described in panel A except that soluble 
0 to 20 pg/ml.  Arg-@gal (W); Cys-@gal (-1; Asp-@gal (W); Glu-@gal (A-A); Asn-@gal (*-e); 
(non-immobilized) RNase A (50 units/mg; Sigma) was used, and its  concentration in the extract was varied from 
Gln-@gal (V-V). Panel C, arginylation of X-pgal in reticulocyte extract. Unlabeled X-@gal proteins were 
incubated at  the indicated concentrations in dialyzed, ATP-supplemented reticulocyte extract a t  37 "C in the 
presence of 6.6 pM [3H]arginine, and the incorporation of [3H]arginine into hot trichloroacetic acid-insoluble 
material was assayed as  a function of time. The same (but unlabeled) X-@gal proteins and  the same designations 
were  used in panel B above. Panel D, in lane a, dialyzed, ATP-supplemented, reticulocyte extract containing 6.6 
p~ unlabeled arginine and 0.25 mg/ml of [35S]Arg-@gal  was incubated for 30 min at  37 "C prior to SDS-PAGE 
analysis. In the other  lanes (b-h), dialyzed, ATP-supplemented reticulocyte extract  containing 6.6 pM [3H]arginine, 
and either  no X-Bgal (lane b )  or 0.25 mg/ml of unlabeled Arg-@gal (lane c), Cys-@gal ( l a n e  d) ,  Asp-@gal (lane e ) ,  
Glu-@gal (&ne/), Asn-@gal (laneg),  and Gln-@gal (lane h )  were incubated as in lane a prior to SDS-PAGE analysis. 
The arrowhead indicates the band of (deubiquitinated) -112-kDa X-@gal. The half-open square brackets indicate 
the bands of multiply ubiquitinated @gal. See "Experimental Procedures" for details. 
dation. In the experiments described below, we used the 
complete set of metabolically unstable X-@gal proteins  in  the 
reticulocyte extract  and  in yeast cells to examine rigorously 
and systematically the role of amino acid conjugation in 
protein degradation. In doing so, we identified Cys as a 
previously unknown secondary destabilizing residue in  retic- 
ulocytes (in  addition to Asp and Glu) and discovered a new 
class of tertiary destabilizing residues. 
Preincubation of the reticulocyte extract with RNase A 
completely prevented the degradation of five X-@gal proteins 
(Cys-, Asp-, Glu-, Asn-, and Gln-@gal),  partially  inhibited the 
degradation of Ala-, Ser-, and Thr-@gal, but did not signifi- 
cantly affect the degradation of the remaining seven short- 
lived X-@gal proteins (His-, Lys-, Arg-, Phe-, Leu-, Trp-,  and 
Tyr-@gal) (Fig. 5 ,  A and B ) .  Preincubation of the  extract with 
2 pg/ml of RNase  A  under the above conditions was sufficient 
to prevent the degradation of Cys-, Asp-, Glu-, Gln-, and Asn- 
@gal (Fig. 5B) ,  whereas much greater amounts of RNase  A 
(>IO pg/ml) were needed for an even partial inhibition of 
degradation of Ala-, Ser-, and Thr-@gal (data not shown). 
Supplementing  RNase-treated extract with either  total bovine 
tRNA or total RNA isolated from reticulocyte extract almost 
completely restored the degradation of Cys-, Asp-, Glu-, 
Gln-,  and Asn-@gal but did not relieve the  partial inhibition 
of the degradation of Ala-, Ser-, and Thr-@gal (Fig. 5A and 
data not shown). Thus,  the degradation of Ala-, Ser-, and 
Thr-@gal apparently does not require tRNA  and hence does 
not require amino acid conjugation; this conclusion is sup- 
ported also by the results of amino acid sequencing of these 
test proteins (see Table I) and by the results of dipeptide 
inhibition  experiments (see below). Amounts of RNase A that 
inhibited the tRNA-dependent degradation of a  protein such 
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as Asp-@gal also inhibited its ubiquitination (data  not shown). 
To detect amino acid conjugation to X-pgal, we incubated 
unlabeled X-@gal protleins in the reticulocyte extract supple- 
mented with ATP,  an ATP-regenerating system, and various 
3H-amino acids. Efficient incorporation of  added [3H]arginine 
into hot trichloroacetic acid-insoluble material was  observed 
with samples containing Cys-, Asp-, Glu-, Gln-, and Asn-pgal 
(Fig. 5 C ) .  Analysis of the same samples by SDS-PAGE indi- 
cated that  the [3H]arginine-derived radioactivity comigrated 
exclusively with the X-@gal proteins  and  their ubiquitin con- 
jugates in the sample (Fig. 5 0 ) .  At the same time, virtually 
no incorporation of t3H]arginine into  hot trichloroacetic acid- 
insoluble material occurred in the otherwise identical samples 
that either lacked X-13gal proteins or contained Ala-, Ser-, 
Thr-, Arg-, or Lys-@gal  (Fig. 5,  C and D and  data  not shown). 
At least the bulk of [3H]arginine has been shown to be 
conjugated specifically to  the amino termini of X-pgal pro- 
teins (Chau et al., 198,9). Although histidinylation has been 
suggested to be  involved in the degradation of some proteolytic 
substrates (Ferber and Ciechanover, 1987), we detected no 
incorporation of added [3H]histidine into  any of the five X- 
@gal proteins whose degradation was tRNA-dependent in  the 
reticulocyte extract, n.or into any of several other X-@gal 
proteins, including Ala-, Ser-,  and Thr-Bgal. We also detected 
no incorporation of [3H]Lys, Phe, Leu, Tyr, Trp and  Ser  into 
hot trichioroacetic acid-insoluble material in analogous ex- 
periments with X-pgal proteins in reticulocyte extract  (data 
not shown). 
Amino acid sequencing of Asp-pgal and Glu-pgal reisolated 
from either  the ATP-depleted reticulocyte extract,  the  ATP- 
supplemented Fraction. I1 or s. cerevisiae cells directly con- 
firmed, in  both yeast and reticulocytes, that  the amino termini 
of Asp-@gal and Glu-@:gal  were conjugated to Arg (Table I). 
The observed conjugation of Arg to Cys-pgal, as well as  to 
Asp- and Glu-pgal in reticulocyte extract (Fig. 5 )  is consistent 
with the known substrate specificity of the isolated mamma- 
lian arginyl-tRNA-protein transferase that catalyzes these 
reactions (Soffer, 1980). We conclude that Asp and Glu are 
secondary destabilizing residues in both yeast and mammalian 
reticulocytes, whereas lCys is a secondary destabilizing resi- 
dues in reticulocyte extract  but  not  in yeast cells  where it is 
a stabilizing residue.  Although the tRNA dependence of the 
degradation of Asn-pgal and Gln-pgal in reticulocyte extract 
(Fig. 5, A and B )  was consistent with Asn and Gln being 
secondary destabilizing residues as well, further analysis has 
shown that these residues belong to a new class. 
Tertiary Destabilizing Residues-Amino acid sequencing of 
Asn-@gal and Gln-pgal reisolated from either the ATP-de- 
pleted reticulocyte extract, the ATP-supplemented reticulo- 
cyte Fraction 11, or ye& (S .  cereuisiae) cells indicated that 
Asn and Gln at the amino termini of these proteins were 
deamidated to Asp and Glu,  respectively, apparently before 
their conjugation to Arg (Table I). Consistent with this result, 
the isolated mammalian arginyl-tRNA-protein transferase 
efficiently arginylates amino-terminal Asp and Glu but does 
not arginylate amino-terminal Gln (Soffer, 1980). 
In control experiments, we ruled out the possibility that  the 
amino-terminal Gln or Asn could be undergoing nonenzy- 
matic deamidation during the isolation of X-@gal from either 
E. coli, yeast cells,  or reticulocyte extract. Site-directed mu- 
tagenesis was used to modify the E. coli expression vector 
encoding Ub-Gln-@gal such that  the last four codons of the 
ubiquitin reading frame specified Ile-Glu-Gly-Arg, the se- 
quence recognized by Factor Xa, one of the proteases in the 
blood clotting cascade (see “Experimental Procedures”). 
Digestion of the purified Ub-(Xa)-Gln-pgal protein with pu- 
rified Factor Xa resulted in  an X-pgal-sized product which, 
after  a mock incubation in the absence of reticulocyte extract, 
followed by amino acid sequencing, was identified as Gln-@gal 
(see “Experimental Procedures”). On the  other hand, when 
the same incubation was carried out in reticulocyte extract, 
the amino-terminal Gln of Gln-pgal was found to be converted 
to Glu. This conversion was prevented by treating reticulocyte 
extract with the thiol blocking reagent N-ethylmaleimide 
prior to  the addition of Gln-@gal (data  not shown). 
We conclude that  the deamidation of Gln-pgal and Asn- 
Pgal after incubation in reticulocyte extract is due to enzy- 
matic deamidation and  not to  the later  steps of reisolation 
and handling of the  test protein prior to amino acid sequenc- 
ing. We therefore suggest that Asn and Gln be designated 
tertiary destabilizing residues, i.e. amino-terminal residues 
that are not destabilizing as such but become so only through 
their ability to be converted, via enzymatic deamidation, into 
the secondary destabilizing residues Asp and Glu. 
The existence of tertiary destabilizing residues in  both yeast 
and mammalian cells implies the existence of a deamidase(s) 
specific for the amino-terminal Asn and Gln residues. An 
enzyme with this specificity remains to be directly identified. 
We have recently isolated a S. cerevisiae mutant in which 
Asn-pgal (but not the other short-lived X-pgal proteins) is 
metabolically stable, suggesting a  mutation  in  a gene for the 
deamidase? To our knowledge, the only previously character- 
ized example of enzymatic deamidation in proteins is the 
deamidation of specific Gln residues in bacterial chemotaxis 
receptors (Kehry et  al., 1983;  Terwilliger and Koshland, 1984). 
Metabolic Instability of X-pgal Bearing a Destabilizing 
Amino-terminal Residue Is Independent of the  Ubiquitin  Fu- 
sion Technique Used to Generate X-@gal-Purified  Gln-pgal 
produced in  vitro using the Factor Xa technique (see above 
and “Experimental Procedures”) was as short-lived upon its 
addition to  the ATP-supplemented reticulocyte extract  as was 
Gln-@gal produced via deubiquitination of the Ub-Gln-pgal 
protein in the same extract (Table I and data not shown). 
Furthermore, the degradation of the Factor Xa-produced Gln- 
@gal  was accompanied by the formation of multiply ubiquitin- 
ated pgal species indistinguishable from those observed with 
Gln-pgal that had been produced  from Ub-Gln-@gal (Fig.  3, B 
and C and data not shown). These results ruled out the 
possibility that  the temporal and spatial proximity between 
deubiquitination of Ub-X-@gal and degradation of the result- 
ing X-pgal might have masked some additional role of the 
deubiquitination step in the subsequent degradation of X- 
@gal. 
Three N-end-recognizing Activities in Reticulocytes-In a 
recent work, Reiss et al. (1988) have shown that certain 
dipeptides (as well as other carboxyl-terminal amino acid 
derivatives such as amino acid esters) specifically inhibit the 
degradation of some proteolytic substrates in ATP-supple- 
mented reticulocyte extract.  In particular, dipeptides having 
a basic amino-terminal residue (Arg, Lys, or His) inhibited 
both the degradation and ubiquitination of proteolytic sub- 
strates such as lysozyme and oxidized RNase A that have a 
basic residue (Lys) at their amino termini (Reiss et  al., 1988). 
On the  other  hand, dipeptides having a bulky hydrophobic 
amino-terminal residue (Phe, Leu, Trp, or Tyr) inhibited both 
the degradation and ubiquitination of proteolytic substrates 
such as @-lactoglobulin and pepsinogen  which  have a bulky 
hydrophobic residue (Leu) at their amino termini. 
These  and  other findings indicated that dipeptides compet- 
itively inhibit  the binding of a proteolytic substrate’s amino- 
terminal residue (a primary destabilizing residue, in the  N- 
R. Baker and A. Varshavsky,  unpublished data. 
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end rule terminology) to  the previously defined E3 component 
of ubiquitin-protein ligase. Thus,  as suggested earlier (Bach- 
mair et al., 1986), E3 is the N-end-recognizing protein or at 
least a component thereof. We used the approach of Reiss et 
al. (1988) together with the complete set of short-lived X-Pgal 
proteins, to determine systematically the number of distinct 
N-end-recognizing (E3) activities in reticulocyte extract. In 
doing so, we identified a previously unknown N-end-recogniz- 
ing activity specific  for  Ala, Ser, and  Thr, which are primary 
destabilizing residues in reticulocytes but stabilizing residues 
in yeast (Table I). 
As shown in Table I1 and Fig. 6D, the dipeptide His-Ala 
specifically inhibited the degradation of X-pgal proteins 
whose amino-terminal residues were either basic (Arg, Lys, 
His) or those (Asp,  Glu, A m ,  Gln, Cys)  which acquired a basic 
amino-terminal residue as  the result of enzymatic conjugation 
of  Arg (see  Figs. 7 and 8, and Table I).  The dipeptide Trp-Ala 
specifically inhibited the degradation of X-@gal proteins bear- 
ing bulky hydrophobic residues (Phe, Leu, Trp, or Tyr) at 
their amino termini (Table I1 and Fig. 6C). Neither His-Ala 
nor Trp-Ala, nor an equimolar mixture of these dipeptides 
inhibited the degradation of Ala-, Ser-, and Thr-pgal, the only 
X-@gal proteins (in addition to Cys-pgal) that  are short-lived 
in reticulocytes but long-lived in yeast (Table 11, Figs. 6, C 
and D, and 7, and  data not shown). However, the dipeptides 
Ser-Ala and Ser-Gly did inhibit the degradation of Ala-, Ser-, 
O0Y F 
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dation by dipeptides. %-Labeled Lys-pgal (U), Phe-@gal 
FIG. 6.  Amino terminus-specific inbibition of j3gal degra- 
(A-A), Ala-@gal (V-V), Thr-pgal (+--+), and Ser-pgal 
(c”.) were incubated in ATP-supplemented reticulocyte extract 
in the presence of bestatin at 40 rg/ml (Reiss et al., 1988) and 
increasing concentrations of specific peptides (obtained from Bachem 
Bioscience, Philadelphia, PA). Degradation of  X-Bgal was assayed by 
measuring the amount of acid-soluble radioactivity after 2 h at 37 “C 
and is plotted against the degradation of @gal in the otherwise 
identical control reactions carried out  in the absence of added pep- 
tides. The peptides used  were Val-Ala ( A ) ,  Ile-Ala ( B ) ,  Trp-Ala ( C ) ,  
His-Ala (D), and Ser-Ala ( E ) .  In F ,  the degradation of 35S-labeled 
Ser-@gal was assayed in the presence of increasing amounts of the 
following peptides: Ser-Ala (A-A), Ala-Ser (W), Ser-Gly 
(0-O), and Ser-Gly-Gly (U). See “Experimental Proce- 
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FIG. 7. Structure of N-end rule. The  terms primary, secondary, 
and tertiary destabilizing amino-terminal residues have been defined 
in the main text  and in Fig. 8. Type I, IT, and III refer to  the specific 
classes of destabilizing amino-terminal residues that are recognized 
(either directly or indirectly; see Fig. 8) by distinct  types of the  N- 
end-recognizing (E3) activity in reticulocytes, as discussed in the 
main text. Unlike the above classification categories, the distinction 
between stabilizing and destabilizing amino-terminal residues is in 
part heuristic because X-@gal proteins with different “stabilizing” 
amino-terminal residues have detectably different metabolic stabili- 
ties (see Table I and “Discussion”). The N-end rule shown is that of 
mammalian (rabbit) reticulocytes. The yeast (S .  cereuisiae) N-end 
rule differs in having Ala, Ser, Thr,  and Cys (bored) as stabilizing 
residues and Ile (rounded  frame) as a destabilizing residue (see Table 
1). 
and Thr-Pgal in reticulocyte extract, although the  extent of 
inhibition was smaller than  that observed with His-Ala, Trp- 
Ala, and  their cognate X-@gal proteins (Table I1 and Fig. 6, E 
and F). The relatively weak inhibition of the degradation of 
Ser-@gal by Ser-Ala and Ser-Gly could be augmented by 
increasing the inhibitor size to  a tripeptide such as Ser-Gly- 
Gly  (Fig. 6F). None of these peptides inhibited the degrada- 
tion of Lys-@gal and Phe-@gal which have a basic and  a bulky 
hydrophobic residue, respectively, at their amino termini 
(Table 11, Fig. 6E, and  data  not shown). The relatively weak 
interaction of Ser-Ala and Ser-Gly with the putative binding 
site for Ala-, Ser-, and Thr-@gal in  a N-end-recognizing (E3) 
protein may account for our inability to detect specific inhi- 
bition of the degradation of test  proteins by Ala-Ala, Ala-Ser, 
and  Thr-Ala dipeptides (Fig. 6F and  data not shown). This 
interpretation is also consistent with the fact that Ser-@gal is 
a shorter-lived protein in reticulocyte extract than either Ala- 
pgal or Thr-@gal (Table I). In agreement with the earlier 
evidence (Reiss et al., 1988), amounts of a dipeptide that 
inhibited the degradation of a specific set of X-@gal proteins 
also inhibited their ubiquitination in reticulocyte extract  (data 
not shown). 
The dipeptide Ile-Ala did not inhibit the degradation of 
either Ser-pgal or Lys-@gal but did  weakly inhibit  the degra- 
dation of Phe-@gal whose amino-terminal residue is bulky and 
hydrophobic  (Fig. 6B). This result is consistent with the fact 
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FIG. 8. The N-end rule pathway. The designations used are: d ,  tertiary destabilizing amino-terminal residues 
Asn or Gln, which are destabilizing through their ability to be converted, via selective deamidation, into the 
secondary destabilizing residues, Asp or Glu, respectively; d,, secondary destabilizing amino-terminal residues, Asp 
or Glu (and also Cys in reticulocytes; see Table I and Fig. 7), which are destabilizing through  their ability to be 
conjugated t o  a primary destabilizing residue, dp (largely, but not necessarily exclusively, Arg). The dotted oval 
denotes the rest of a protein molecule. The N-end-recognizing protein is denoted as E3, since the properties of a 
mammalian protein E3, whose presence is required for ubiquitination of proteolytic substrates by E2 enzymes in 
uitro (Hershko, 1988) strongly suggest that E3 is the N-end-recognizing protein or at least a component thereof 
(see main text). E l  and E2, ubiquitin-activating and ubiquitin-conjugating enzymes, respectively. u, ubiquitin. The 
designation [. . . .lUn denotes the targeted protein which contains  a multiubiquitin chain of n ubiquitin moieties 
branch conjugated to each other via a Gly-76/Lys-48 isopeptide bond between adjacent ubiquitins, and joined (via 
the carboxyl-terminal Gly-76 of the first ubiquitin moiety in the chain) to a specific Lys residue of the target 
protein (Chm et al., 1989;  see also Bachmair and Varshavsky (1989), and  the main text).  The N-end rule pathway 
starts when a newly formed protein is proteolytically processed in uiuo to expose one of the  three distinct types of 
destabilizing amino-terminal residues, d ,  d,, or dp For instance, if an initially processed protein bears one of the 
two tertiary (d , )  destabilizing amino-terminal residues (Asn or Gln), it is selectively deamidated at  the amino 
terminus, yielding the amino-terminal d. residue (Asp or Glu, respectively), which is then conjugated to a primary 
destabilizing residue, dp (see above). The amino-terminal d, residue is bound by the N-end-recognizing protein 
(E3), and, if the second determinant of the amino-terminal degradation signal is present  as well (see Bachmair 
and Varshavsky (1989), and  the main text),  the protein is targeted for multiple ubiquitination and subsequent 
selective degradation. The deamidation route is bypassed when the exposed amino-terminal residue in an initially 
processed protein is a secondary destabilizing residue, d, (see Fig. 7). If the initial proteolytic processing yields a 
primary destabilizing residue, d,, at  the protein’s amino terminus, the protein is targeted for ubiquitination directly, 
bypassing the amino acid conjugation step as well. Although E3 is shown to recycle after the ubiquitination step, 
other possibilities are also not precluded by the presently available evidence (see Bachmair and Varshavsky, 1989). 
Note that by not specifying the positions of relevant destabilizing residues within a  protein, this scheme implicitly 
incorporates the possibility of proteolytic processing of either newly formed or preexisting proteins that could 
expose destabilizing residues far away from the protein’s initial amino terminus. See main text for additional 
details and discussion. 
that Ile, also a bulky :hydrophobic residue, is a “borderline” 
stabilizing residue in reticulocytes and a destabilizing residue 
in yeast (see Table I, Fig. 7, and discussion above). The 
dipeptide Val-Ala did not inhibit the degradation of either 
Lys-, Phe-,  Ser-, Ala-, or Thr-pgal (Fig. 6A), consistent with 
the fact that Val is the strongest stabilizing residue in the 
reticulocyte N-end rule (Table  I). 
The dipeptide His-A.la, while inhibiting the degradation of 
X-pgal proteins with basic amino-terminal residues, stirnu- 
luted the degradation of X-@gal  with bulky hydrophobic 
amino-terminal residules (Fig. 6D and  Table 11). One expla- 
nation of this effect is that dipeptides with basic amino- 
terminal residues inhihit  the degradation of abundant endog- 
enous substrates with basic amino termini  in  the reticulocyte 
extract, and thereby reduce competition for some limiting 
component of the proteolytic pathway. Since His-Ala did not 
stimulate the degradation of Ala-, Ser-,  or  Thr-pgal (Fig. 6D), 
the hypothetical limiting  component of the proteolytic path- 
way is apparently not limiting in the degradation of this 
specific subset of short-lived X-pgal proteins. 
These  results (Table I1 and Fig. 6) demonstrated the exist- 
ence of three functional classes of primary destabilizing resi- 
dues, and implied the presence of three  distinct types of N- 
end-recognizing (E3) activities in mammalian reticulocytes. 
Two of these activities (those specific for bulky hydrophobic 
and basic amino-terminal residues) have been inferred previ- 
ously by Reiss et al. (1988). The  third activity, specific for 
small  uncharged destabilizing amino-terminal residues, Ala, 
Ser, and  Thr, was identified in the present work. 
DISCUSSION 
Structure of the N-End Rule-The hierarchical organiza- 
tion of the  N-end rule that  has been deduced in  the  present 
work is summarized in Fig. 7. It is clear that  at least one 
reason for the existence of several N-end-recognizing (E3) 
activities stems from the mechanistic requirement of recog- 
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TABLE I1 
Specific  inhibition of X-pgal degradation  by  dipeptides 
The effect of specific dipeptides  on the degradation of X-pgal test 


















Degradation of X-@gal (% of control) in 
the presence of a dipeptide 
His-Ala Trp-Ala Ser-Ala 
2 mM 2 mM 5 mM 
20  76 95 
9  70 81 
12 67 51 
15 90 110 
12 78 98 
24 87 111 
16 77  72 
1 2  75 83 
160 6 82 
151 27 97 
132 8 83 
127 11 74 
85 64 16 
84 92 26 
80  71 17 
nizing a chemically diverse set of primary destabilizing amino- 
terminal residues. The Type  I E3 activity is specific for the 
set of destabilizing residues (Arg, Lys, His) whose common 
property is positive charge. The Type I1 E3 activity is specific 
for the set of bulky hydrophobic destabilizing residues, Phe, 
Leu, Trp,  Tyr  (and apparently also Ile in yeast; see below). 
The Type I11 E3 activity, present in reticulocytes but  appar- 
ently absent from yeast (Table I and Fig. 7),  is specific for 
the  set of destabilizing residues (Ala, Ser, Thr)  that  share  the 
properties of small size and lack of charge. It is likely, but 
remains to be proven, that these three N-end-recognizing 
activities correspond to more than one species of E3 protein. 
A priori, the recognition of other chemically distinct sets of 
destabilizing amino-terminal residues such as Asp/Glu and 
Asn/Gln could be achieved by a similar E3-dependent mech- 
anism, with the corresponding N-end-recognizing (E3)  pro- 
teins being specific for either negatively charged amino-ter- 
minal Asp and Glu or their respective amides. However, the 
recognition of amino-terminal Asn/Gln and Asp/Glu (and 
also of Cys in reticulocytes) proceeds instead via a hierarchical 
system that conjugates these amino-terminal residues to a 
primary destabilizing residue (largely, but possibly not exclu- 
sively, Arg in both yeast and reticulocytes) (Fig. 7). This 
conjugation, carried out by a specific class of enzymes, ami- 
noacyl-tRNA-protein transferases, proceeds directly with the 
secondary destabilizing residues, Asp and Glu (and also Cys 
in reticulocytes), but is preceded by a deamidation reaction 
in the case of the  tertiary destabilizing residues, Asn and Gln 
(Figs. 7 and 8). Whether these seemingly avoidable enzymatic 
complexities serve specific regulatory functions  remains to be 
determined. 
Although most of the amino-terminal residues that confer 
short half-lives on X-pgal in yeast are destabilizing in  retic- 
ulocyte extract  as well, a closer examination of Table I shows 
that  the relative degree of destabilization by a given residue 
is, in general, not the same in yeast and reticulocytes, even 
though the corresponding test protein X-pgal, is apparently 
the same in both cases. At the same time, arranging the 
primary destabilizing residues according to the type of E3 
activity that recognizes them  (Table 111) reveals distinct  areas 
of quantitative conservation between the yeast and reticulo- 
TABLE 111 
Comparison of destabilizing  residues in yeast  and  reticulocytes 
The half-life data of Table I were combined with the assignments 
of specific destabilizing residues to different classes (primary,  second- 
ary,  tertiary;  type I, 11,111) that have been established in  the  present 
work (Figs. 5, 6, and  Table 11). The resulting arrangement reveals a 
greater similarity between quantitative aspects of the yeast and 
Table I. 
reticulocyte N-end rules than is apparent from the  arrangement  in 
Half-life of X-opal 
Yeast Reticulocytes 
(in uiuo) (in uitro) 
Primary destabilizing residue X 
‘ Arg 2 min 1.0 h 
Type I . 
His 10 min 3.5 h 
Lys 3 min 1.3 h 
Phe 3 min 1.1 h 
Leu 3 min 5.5 h 
Type I1 Trp 3 min 2.8 h 
TY r 10 min 2.8 h 
Ile 30 min 20 h 
’ Ala >20 h 4.4 h 
Type 111 Ser >20 h 1.9 h 
Thr >20 h 7.2 h 
Secondary  destabilizing residue X 
ASP 3 min 1.1 h 
Glu 30 min 1.0 h 
CYS >20 h 1.2 h 
Tertlary destabilizing residue X 
Asn 3 min 1.4 h 
Gln 10 min 0.8 h 
cyte N-end rules. In particular, the order of destabilizing 
“capacities” of the Type I primary destabilizing residues is 
the same  in  yeast and reticulocytes (Table 111). This is also 
partly true for the Type I1 primary destabilizing residues, the 
conspicuous deviations being Leu and Ile, which are much 
less destabilizing in reticulocytes than in yeast (indeed, Ile is 
a “borderline” stabilizing residue in reticulocytes; see Fig. 7, 
Tables I and 111, and discussion above). Both Leu and Ile 
have branched side chains, in  contrast  to  the  other ydropho- 
bic destabilizing residues, Phe, Tyr, and Trp, which have 
aromatic side chains. Thus, the observed difference in the 
relative destabilizing capacities of Leu and Ile between yeast 
and reticulocytes may  be due to a  greater  discrimination by 
the reticulocyte Type I1 E3 protein  against  branched hydro- 
phobic residues, possibly because of the need to maximize the 
metabolic stability of proteins with amino-terminal Val, a 
smaller branched hydrophobic residue. Val is the strongest 
stabilizing residue in the reticulocyte N-end rule (Table I) 
and occurs in  particular at  the mature  amino termini of both 
a- and P-chains of wild-type mammalian hemoglobin (Croft, 
1980), the most abundant protein  in  erythrocytes and  their 
precursors, reticulocytes. 
Gln-pgal, whose amino-terminal residue is a tertiary de- 
stabilizing one, has a half-life of -0.8 h  in reticulocyte extract, 
which is slightly but reproducibly shorter  than  the half-life of 
Arg-pgal (tlh of  -1.0  h; Table  I). Arg, a  primary destabilizing 
residue, is also the one that is conjugated to the amino 
terminus of Gln-pgal, after its preliminary conversion, via 
enzymatic deamidation, into Glu-pgal (Figs. 7 and 8). Thus, 
although it takes two additional enzymatic steps for Gln-@gal 
to acquire the amino-terminal Arg, its half-life is still shorter 
than  that of Arg-pgal with the preexisting amino-terminal 
Arg. What might be the reason for this apparently paradoxical 
result? One consequence of Arg conjugation is the 1-residue 
increase in  a  distance between the first determinant of an X- 
pgal’s degradation signal (the amino-terminal residue of X- 
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@gal) and  the second determinant of the same degradation 
signal (a specific internal Lys residue of X-@gal)  (Bachmair 
and Varshavsky, 1989). This increase is likely to augment the 
strength of the degradation signal (see Bachmair and Var- 
shavsky (1989) for the definition and discussion of the amino- 
terminal degradation signal). It is also possible that  the above 
effect is due to a modulating influence of the second residue 
in  a  target  protein (Glu in Arg-Glu-His-Gly-@gal and His in 
Arg-His-Gly-@gal) (see Bachmair  et al., 1986; Bachmair and 
Varshavsky, 1989). Yet another possibility is that enzymes 
which act on seconda.ry and tertiary destabilizing residues 
may influence kinetics of subsequent  targeting  steps, possibly 
through a physical as,sociation with “downstream” compo- 
nents of the degradative pathway (Fig. 8). 
Are Long-lived and Short-lived X-@gal Proteins Degraded 
by a Common Pathway?-Long half-lives of the X-@gal pro- 
teins which bear stabilizing amino-terminal residues can be 
considered a “default”’ consequence of the absence of E3 
proteins recognizing these residues. On the  other hand, dif- 
ferent stabilizing residues confer reproducibly different half- 
lives on the corresponding X-@gal proteins in reticulocyte 
extract (Table I). The same  appears to be true of long-lived 
X-@gal proteins in yeast (Bachmair et al., 1986).3 The slow 
degradation of Met-, GIy-, and Ile-@gal in reticulocyte extracts 
is ATP-dependent, and apparently also ubiquitin-dependent 
(Figs. 3, 4, and  data not  shown). If long-lived and short-lived 
X-@gal proteins (Table  I)  are degraded by a common pathway, 
two distinct mechanirjms could account for the presently 
available data: (i) a bite fidelity of the amino-terminal 
recognition of proteolytic substrates would result in rare 
events of binding of stabilizing amino-terminal residues by 
the N-end-recognizing (E3) proteins that normally recognize 
destabilizing amino-terminal residues; and  (ii) a slow proteo- 
lytic “nibbling” at  an X-pgal’s amino terminus which at some 
point exposes a previously internal destabilizing residue at  a 
new amino terminus, followed by rapid degradation of the 
thus modified  @gal. Fine tuning of the  rate of degradation in 
the  latter case may  be a  function of the  rate of  slow amino- 
terminal cleavage that exposes a destabilizing residue, rather 
than a  function of the residue’s destabilizing capacity accord- 
ing to  the N-end rule. I t  remains to be seen whether these 
mechanisms are relevant to  the degradation of long-lived X- 
@gal proteins  or, more generally, to  the degradation of natu- 
rally occurring long-lived intracellular  proteins. 
The N-End Rule Pathway-The degradative pathway 
whose initial steps involve amino-terminal recognition of 
proteolytic substrates is called the  N-end rule pathway (see 
Fig. 8 and  its legend), to  distinguish it from other proteolytic 
pathways and also from other ubiquitin-dependent processes 
(Jentsch et al., 1987; IBall et al., 1987; Goebl et al., 1988; 
Siegelman and Weissman, 1988; Dunigan et al., 1988; Pickart 
and Vella,  1988; Haas  and Bright, 1988). Targeting by the  N- 
end rule pathway requires the generation of a destabilizing 
residue at  the amino terminus of a proteolytic substrate; the 
rules and mechanisms of these early events for the physiolog- 
ically relevant substrates of the  N-end rule pathway remain 
to be understood. 
The consistent absenlze  of 12  amino acids that  are destabi- 
lizing according to  the yeast N-end rule (Table I) from the 
mature  amino termini (of relatively long-lived, noncompart- 
mentalized proteins  (Bachmair et al., 1986) is largely due to 
the  substrate specificity of the enzyme methionine  aminopep- 
tidase. In both  bacteria and eukaryotes, this enzyme (Tsuna- 
sawa et al.,  1985;  Ben-ELassat et aL,  1987; Miller et al.,  1987; 
Huang et al., 1987; Boissel et al.,  1988; Arfin and Bradshaw, 
A. Bachmair and A. Varshavsky, unpublished results. 
1988) cleaves off the amino-terminal  Met residue if and only 
if it is not followed either by another Met residue or by any 
of the 12 residues that  are destabilizing according to yeast  N- 
end rule. Such cleavage specificity would be functionally 
relevant if the amino-terminal exposure of a (penultimate) 
destabilizing residue were to confer short half-lives on at  least 
some of the otherwise long-lived proteins that normally retain 
their amino-terminal methionine. The inverse correspond- 
ence between the yeast  N-end rule and  the  substrate require- 
ments of the methionine aminopeptidase provides a  partial 
functional  explanation for the properties of this enzyme: a 
methionine-clipping aminopeptidase that is involved in proc- 
essing of long-lived proteins would be expected not to expose 
a residue whose presence at  the amino terminus might desta- 
bilize the  substrate protein. 
We suggest that analogous, still to be identified proteases 
may be responsible for the generation of amino  termini  bear- 
ing either primary, secondary, or tertiary destabilizing resi- 
dues (Fig. 8) in specific proteins. An example of a noncom- 
partmentalized  short-lived  protein whose amino-terminal 
processing yields a destabilizing amino-terminal residue is the 
phage X cII protein, which is central to  the lysis-lysogeny 
decision by X, and in which the  third residue, Arg, is found at  
the mature  amino terminus (Ho et al., 1986). (The existence 
of aminoacyl-tRNA-protein  transferases  in  bacteria (Soffer, 
1980), and a strong bias against destabilizing amino-terminal 
residues in long-lived, noncompartmentalized  proteins  from 
both  bacteria and eukaryotes  (Bachmair et al., 1986) suggest 
that a  N-end rule pathway  exists  in  bacteria as well. Experi- 
mental testing of this conjecture is under way.) Specific 
endoproteolytic cleavages anywhere in a  protein should also 
be able to generate destabilizing residues at  the amino  termini 
of cleavage products, and may be involved, for instance,  in 
the targeting of damaged or otherwise abnormal  proteins by 
the N-end rule pathway (Varshavsky et al.,  1988; Bachmair 
and Varshavsky, 1989). 
Not shown explicitly in Fig. 8 are  three  important mecha- 
nistic  features of the  N-end rule pathway. One is the demon- 
strated multiplicity of the N-end-recognizing (E3) activities 
(see above and Figs. 6 and 7). The  other is a bipartite  nature 
of the amino-terminal degradation signal which has been 
shown to comprise two distinct  determinants (Bachmair and 
Varshavsky, 1989). One determinant, discovered previously 
(Bachmair et al., 1986) and studied  in the present work  (d, in 
Fig. 8), is the amino-terminal residue of a proteolytic sub- 
strate.  The second determinant is a specific, internal lysine 
residue of a proteolytic substrate (Bachmair and Varshavsky, 
1989). Also not shown explicitly in Fig. 8 is the recently 
deciphered structure of a multiply ubiquitinated X-@gal pro- 
tein  in which an ordered chain of branched ubiquitin-ubiquitin 
conjugates was shown to be confined to a lysine residue that 
had been identified by molecular genetic analysis as the 
second determinant of the degradation signal (Chau et al., 
1989; Bachmair and Varshavsky, 1989). 
Is the Exact Form of the N-end Rule a  Function of the Cell’s 
Physiological State?-Metabolic instability of the Ala-, Ser-, 
Thr-,  and Cys-@gal proteins  in reticulocytes and  their stability 
in  yeast is the major, qualitative difference between the yeast 
and reticulocyte N-end rules (Fig. 7 and Tables I and 111). 
Since Cys is a secondary destabilizing residue in reticulocytes 
(Figs. 7 and 8), the metabolic stability of Cys-@gal in  yeast 
(Tables I and 111) may  be due to  the lack of arginylation of 
Cys-@gal in yeast, either because of a difference between 
substrate specificities of the yeast and reticulocyte arginine- 
tRNA-protein  transferases or because Cys-@gal is amino ter- 
minally blocked in  yeast cells but not  in reticulocyte extract. 
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Amino acid sequencing of reisolated X-pgal test proteins 
showed that the amino termini of Ala-pgal and Thr-pgal 
(which, in  addition to Ser-pgal and Cys-@gal, are short-lived 
in reticulocytes but long-lived in  yeast)  are unblocked in  both 
yeast cells and reticulocyte extract (Table I). The amino 
terminus of Ser-@gal was found to be blocked, presumably by 
acetylation, in yeast cells but not in reticulocyte extract 
(Table I). Thus, a “yeast-specific” amino-terminal modifica- 
tion (e.g. acetylation) of Ala- and Thr-pgal cannot be an 
explanation of the striking difference in relative metabolic 
stabilities of these test proteins between reticulocytes and 
yeast. These results, and our  finding that Ala-, Ser-,  and  Thr- 
pgal are  targeted for degradation by a distinct N-end-recog- 
nizing (E3) activity in reticulocytes (Figs. 6 and 7 and  Table 
11) are  consistent with the possibility that yeast cells lack the 
Ala-, Ser-,  Thr-specific E3 activity. 
The “Ala, Ser, Thr” divergence between the yeast and 
reticulocyte N-end rules (Fig.  7) appears particularly signifi- 
cant in view  of the fact that Ala, Ser, and  Thr are among the 
amino-terminal residues often  present  in long-lived, noncom- 
partmentalized  intracellular  proteins  (Bachmair et al., 1986; 
Croft, 1980; Flinta et al., 1986; Tsunasawa et al., 1985). This, 
together with the presence in reticulocytes of a distinct  N- 
end-recognizing (E3) activity specific for Ala, Ser, and  Thr 
(Figs. 6 and 7 and Table 11), leads us to suggest that  the 
metabolic instability of Ala-, Ser-,  and Thr-pgal  in reticulo- 
cytes may  be due to a reticulocyte-specific variant of the  N- 
end rule. Selective degradation of undamaged, previously 
long-lived proteins is unusually extensive during the conver- 
sion of reticulocytes into erythrocytes but apparently occurs 
(and may be essential) in most if not all other cell lineages as 
well. This putative  differentiation-dependent  protein degra- 
dation via the N-end rule pathway could be achieved through 
the regulation of either specific N-end-recognizing (E3) pro- 
teins  or enzymes that act upon primary, secondary, and  ter- 
tiary destabilizing residues (Fig. 8). If the exact form of the 
N-end rule is indeed a function of the cell’s physiological 
state, it could provide a mechanism for selective destruction 
of preexisting, otherwise long-lived and undamaged proteins 
during cell differentiation, cell cycle progression, and  other 
changes in  the cell’s state.  Experimental testing of this pos- 
sibility is under way. 
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